• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
LTSI Consensus Guidelines: Preoperative Cardiac Evaluation in Adult Liver Transplant Recipients.LTSI 共识指南:成人肝移植受者的术前心脏评估
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102419. doi: 10.1016/j.jceh.2024.102419. Epub 2024 Oct 18.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.提高实体器官移植受者免疫抑制剂药物依从性的干预措施。
Cochrane Database Syst Rev. 2022 Sep 12;9(9):CD012854. doi: 10.1002/14651858.CD012854.pub2.
5
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
6
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.在没有明显临床指征的患者和常见合并症患者亚组中,在择期手术前常规检测全血细胞计数、电解质和尿素以及肺功能测试的价值:对临床和成本效益文献的系统评价。
Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500.
7
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
8
Interventions to prevent surgical site infection in adults undergoing cardiac surgery.预防接受心脏手术的成人手术部位感染的干预措施。
Cochrane Database Syst Rev. 2024 Dec 2;12(12):CD013332. doi: 10.1002/14651858.CD013332.pub2.
9
Practical dietary interventions to prevent cardiovascular disease suitable for implementation in primary care: an ADAPTE-guided systematic review of international clinical guidelines.适合在初级保健中实施的预防心血管疾病的实用饮食干预措施:一项基于 ADAPTE 指南的国际临床指南系统评价。
Int J Behav Nutr Phys Act. 2023 Jul 28;20(1):93. doi: 10.1186/s12966-023-01463-9.
10
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复。
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.

本文引用的文献

1
The burgeoning cardiovascular disease epidemic in Indians - perspectives on contextual factors and potential solutions.印度心血管疾病流行趋势——关于背景因素及潜在解决方案的观点
Lancet Reg Health Southeast Asia. 2023 Feb 10;12:100156. doi: 10.1016/j.lansea.2023.100156. eCollection 2023 May.
2
LTSI Consensus Guidelines: Preoperative Pulmonary Evaluation in Adult Liver Transplant Recipients.LTSI 共识指南:成人肝移植受者的术前肺部评估
J Clin Exp Hepatol. 2023 May-Jun;13(3):523-531. doi: 10.1016/j.jceh.2022.12.012. Epub 2022 Dec 26.
3
Drug-eluting stent use with abbreviated dual antiplatelet therapy after percutaneous coronary intervention for liver transplantation evaluation.肝移植评估经皮冠状动脉介入治疗后使用药物洗脱支架与简化双联抗血小板治疗。
Liver Transpl. 2023 Apr 1;29(4):459-462. doi: 10.1097/LVT.0000000000000090. Epub 2023 Feb 7.
4
Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease.糖尿病与非酒精性脂肪性肝病合并肝硬化患者肝细胞癌风险的关系。
Gut Liver. 2023 Jan 15;17(1):24-33. doi: 10.5009/gnl220357. Epub 2022 Dec 19.
5
Anticoagulation in patients with atrial fibrillation and liver cirrhosis.心房颤动合并肝硬化患者的抗凝治疗
Ann Gastroenterol. 2022 Nov-Dec;35(6):557-567. doi: 10.20524/aog.2022.0745. Epub 2022 Oct 3.
6
Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association: Endorsed by the American Society of Transplantation.新兴的肾和肝移植候选者冠心病筛查证据:美国心脏协会的科学声明:得到美国移植学会的认可。
Circulation. 2022 Nov 22;146(21):e299-e324. doi: 10.1161/CIR.0000000000001104. Epub 2022 Oct 17.
7
Approach to the patient with decompensated cirrhosis and aortic stenosis during liver transplantation evaluation.失代偿期肝硬化合并主动脉瓣狭窄患者在肝移植评估中的处理方法。
Hepatol Commun. 2022 Dec;6(12):3291-3298. doi: 10.1002/hep4.2094. Epub 2022 Sep 27.
8
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery.2022年欧洲心脏病学会非心脏手术患者心血管评估与管理指南。
Eur Heart J. 2022 Oct 14;43(39):3826-3924. doi: 10.1093/eurheartj/ehac270.
9
Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality.高血压在非酒精性脂肪性肝病中普遍存在,并增加全因死亡率和心血管疾病死亡率。
Front Cardiovasc Med. 2022 Aug 8;9:942753. doi: 10.3389/fcvm.2022.942753. eCollection 2022.
10
Executive Summary: Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline.摘要:抗血栓治疗的围手术期管理:美国胸科医师学会临床实践指南。
Chest. 2022 Nov;162(5):1127-1139. doi: 10.1016/j.chest.2022.08.004. Epub 2022 Aug 11.

LTSI 共识指南:成人肝移植受者的术前心脏评估

LTSI Consensus Guidelines: Preoperative Cardiac Evaluation in Adult Liver Transplant Recipients.

作者信息

Singh Shweta A, Prakash Kelika, Kajal Kamal, Loganathan Sekar, K Nandakumar, Subramanian Rajkumar, Singh Anil, Choudhary Narendra S, Mukherjee Anindita, Viswanathan Premkumar Giri, Sindwani Gaurav, Ranade Sharmila, Malleeswaran Selva K, Raghu Arun, Mathiyazhagan Radhika, Venkatachalapathy Shamith, Pant Deepanjali, Srivastava Piyush, Kumar Lakshmi, Vohra Vijay, Rajkumar Akila, Narsimhan Gomathy, Goel Anupam, Aggarwal Vinayak, Kumar Ashok, Panackel Charles

机构信息

Department of Anaesthesia and Critical Care - Center for Liver & Biliary Sciences (CLBS), Max Super Speciality Hospital (MSSH), Saket, New Delhi, India.

Department of Anaesthesiology, Pain Medicine & Critical Care AIIMS, New Delhi, India.

出版信息

J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102419. doi: 10.1016/j.jceh.2024.102419. Epub 2024 Oct 18.

DOI:10.1016/j.jceh.2024.102419
PMID:40177699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11959373/
Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among LT candidates and accounts for up to 40% of the overall mortality within one month. It is influenced by traditional and nontraditional risk factors related to end-stage liver disease. A large proportion of CLD patients have underlying cardiovascular disease (CVD) especially if the etiology is metabolic associated steatohepatitis. Despite the large number of liver transplantations being conducted in India, there is a lack of an evidence-based guidelines for screening of CVD in this patient population. This consensus statement from Liver Transplant Society of India (LTSI) is the first attempt for developing an evidence-based document on preoperative cardiac evaluation from India. A task force consisting of transplant-anesthesiologists, transplant hepatologists, liver transplant surgeon and cardiologists from high volume centres was formed which reviewed the existing evidence and literature and formulated graded recommendations. The document focuses on identification of underlying cardiac pathologies, risk stratification and optimisation of modifiable cardiac diseases. Implementation of best practices and optimal strategies should be encouraged to improve cardiovascular outcomes in these populations.

摘要

心血管疾病(CVD)是肝移植候选者发病和死亡的主要原因,在一个月内的总死亡率中占比高达40%。它受与终末期肝病相关的传统和非传统风险因素影响。很大一部分慢性肝病(CLD)患者患有潜在的心血管疾病(CVD),尤其是如果病因是代谢相关脂肪性肝炎。尽管印度进行了大量肝移植手术,但在这一患者群体中缺乏基于证据的心血管疾病筛查指南。印度肝移植协会(LTSI)的这份共识声明是印度首次尝试制定一份关于术前心脏评估的循证文件。一个由来自高容量中心的移植麻醉师、移植肝病学家、肝移植外科医生和心脏病学家组成的特别工作组成立了,该工作组审查了现有证据和文献并制定了分级建议。该文件侧重于识别潜在的心脏病理、风险分层以及可改变的心脏病的优化。应鼓励实施最佳实践和最佳策略,以改善这些人群的心血管结局。